The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000138.5(FBN1):c.2624G>A (p.Cys875Tyr)

CA10587846

264089 (ClinVar)

Gene: FBN1
Condition: Marfan syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: 818ffe7b-d6f4-4191-a8e8-0061ef38117c
Approved on: 2023-12-29
Published on: 2023-12-29

HGVS expressions

NM_000138.5:c.2624G>A
NM_000138.5(FBN1):c.2624G>A (p.Cys875Tyr)
NC_000015.10:g.48495176C>T
CM000677.2:g.48495176C>T
NC_000015.9:g.48787373C>T
CM000677.1:g.48787373C>T
NC_000015.8:g.46574665C>T
NG_008805.2:g.155613G>A
ENST00000684448.1:n.1298G>A
ENST00000316623.10:c.2624G>A
ENST00000316623.9:c.2624G>A
ENST00000537463.6:c.637-20526G>A
NM_000138.4:c.2624G>A
More

Likely Pathogenic

Met criteria codes 5
PM5 PM1 PM2_Supporting PP3 PP2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
FBN1 VCEP
The NM_00138 c.2624G>A is a missense variant in FBN1 predicted to cause a substitution of a cysteine by tyrosine at amino acid 875 (p.Cys875Tyr). This variant has been reported three times in ClinVar: twice as likely pathogenic and once as uncertain significance (Variation ID: 264089). A different missense variant impacting the same residue, p.Cys875Arg has been previously reported in individuals with clinical features of Marfan syndrome and found to segregate with disease in multiple affected relatives from one family (PMID 19293843, 28973303, internal data; PM5). This variant is not present in gnomAD (PM2_sup; https://gnomad.broadinstitute.org/ v2.1.1). This variant affects a cysteine residue in a hybrid domain. Cysteine residues are believed to be involved in the formation of disulfide bridges which are essential for the protein structure (PM1). Computational prediction tools and conservation analysis suggest that this variant may impact the protein (REVEL: 0.986, PP3). The constraint z-score for missense variants affecting FBN1 is 5.06 (PP2). In summary, this variant meets criteria to be classified as likely pathogenic for Marfan syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen FBN1 VCEP: PM1, PM5, PM2_Sup, PP2, PP3.
Met criteria codes
PM5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM1
Impacting a Cys residue in a hybrid domain
PM2_Supporting
Absent in gnomAD v2.1.1
PP3
REVEL 0.986
PP2
z-score is 5.06
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.